Want to use our logo?

Download the ICS Branding Pack

ICS Background

Prof Sherif Mourad
Ain Shams University, Cairo, Egypt

View General Secretary Details

Sherif Mourad

General Secretary

Profession:Urologist
Qualifications:PhD Professor Staff Member Chairman of Department/Section
Privacy:
You must be logged in to view this contact
Sign-in to ICS

Professor of Urology at Ain Shams University, Cairo, Egypt – Subspecialty in Neurourology and Urogynecology.

Director and management of the Obour University Hospital of Ain Shams University including reviewing of all financial issues of the hospital. Managerial skills and receiving a Diploma of Hospital Management (American University) Running and managing the Pan Arab Continence Society

MD Thesis in a subspecialty of Neurourology at McGill University, Montreal, Canada. With special interest in Lower Urinary Tract Disease, Overactive Bladder, Female Urology, and Neurostimulation.

Member of Residents Training Program of Voiding Dysfunction in Urology Department, Ain Shams University.

Active in the International Continence Society (ICS), serving on its Board of Trustees as one of the Executives, also serving on the Educational Committee, Continence Promotion Committee and Currently Chairing the ICS Fistula Committee. Also on the Meetings and Nominations Committee(ICS) - Chairman of the very successful 38th ICS meeting 2008 in Cairo- Director of the ICS course in Abu Dhabi Jan/2007, Sharm El Sheikh 2010 and Dubai 2011.

Founder and President of Pan Arab Continence Society (PACS). Chairman of Scientific Committee of PACS. Past Board Member of the Egyptian Urological Association (EUA) - Founder and Past President of Sector of Voiding Dysfunction and Urodynamics of EUA President of African Fistula and Continence Society.

Member of the Scientific Committee of the World Congress of Lower Urinary Tract Symptoms of the Societe International de Urologie (SIU), Marrakesh 2010.

Member the Taskforce of pelvic Floor Reconstruction of the FIGO (International Federation of Gynecology and Obstetrics).

Currently conducting surgical and educational missions in Africa helping in the treatment of Obstetric Fistulae and training African Doctors how to manage the possible complications. He is the director of the ICS workshops for Surgery of Vaginal Fistula.

Director and one of the Tutors of Middle East Urodynamic Courses of Bristol Urological Institute. The course has been running successfully through last 7 years in many Arab countries and once in Thessaloniki/Greece.

On the Editorial Board of Neurourology and Urodynamics Journal, The Chief Editor of Afro Arab Journal of Voiding Dysfunction and is a reviewer for the International Urogynecology Journal, Neurourology and Urodynamics Journal, Advances in Urology, Urologia Internationalis, and several regional journals.

Conducting a well established training course of Urogynecology in Egypt and receiving trainees of urologists and gynecologists from many countries.

A Guest Speaker, Chairman and Moderator in many regional (Arab) and International events including Asian, European and American scientific meetings.

Active Member of the AUA, EAU, ICS, ICI, SIU, IUGA, FIGO, ICUD, AFFCS, ISOFS ISSM, EUA, AAU and others.

Special Certificates:

  • Certificates in Urodynamic (Bristol Urological Institute – UK)
  • Certificate in Neuromodulation & Neurostimulation (Maastricht University – Netherlands)
  • Certificate in Holmium Laser applications (McGill University – Canada)

Research Activities:

  • A Multicenter Randomized Placebo Controlled Double Blind Study comparing different dosage of Botulinium Toxin A in the Treatment of Neurogenic Detrusor Overactivity in Spinal Cord Injury. (Sponsored by Allergan)

  • On the Advisory board of Overactive Bladder Syndrome in Africa and Middle East (Pfizer AFME)

  • On going research with Wake Forest University – North Carolina on Stem Cell Therapy in the treatment of Urinary Incontinence due to Intrinsic Sphincteric Deficiency.

Prof Sherif Mourad declared on the Tuesday 16th January 2018 that they had the following existing or known future financial relationships or affiliations:

Astellas

  • Speaker Honorarium

Pfizer

  • Speaker Honorarium
  • Trial participation
UP TO DATE!